Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|December 26, 2006
Reversal of agonist selectivity by mutations of conserved amino acids in the binding site of nicotinic acetylcholine receptorsNicole A Horenstein, Thomas J McCormack, Clare Stokes, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphataseMario B Marrero, Roger L Papke, Balwinder S Bhatti, et al.
Molecular Pharmacology|June 24, 2004
A single point mutation confers properties of the muscle-type nicotinic acetylcholine receptor to homomeric alpha7 receptorsAndon N Placzek, Francesca Grassi, Thaddeus Papke, et al.
Biochemical Pharmacology|May 15, 2012
The nicotinic acetylcholine receptors of zebrafish and an evaluation of pharmacological tools used for their studyRoger L Papke, Fumihito Ono, Clare Stokes, et al.
Current Neuropharmacology|August 19, 2017
New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRsDeniz Bagdas, Mine S Gurun, Pamela Flood, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
The characterization of a novel rigid nicotine analog with alpha7-selective nAChR agonist activity and modulation of agonist properties by boron inclusionRoger L Papke, Guangrong Zheng, Nicole A Horenstein, et al.
Central Nervous System Agents in Medicinal Chemistry|August 31, 2016
Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory PathwayMillet Treinin, Roger L Papke, Eran Nizri, et al.
Pageof 14